Patents by Inventor Mark A. Dawson

Mark A. Dawson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9896663
    Abstract: Bromodomain and extra terminal protein (BET) resistant leukemic cell lines and methods for producing such cell lines are described as are methods for using such cell lines in screening assays to identify therapeutic agents. The cell lines can be generated from haematopoietic stem and progenitor cells (HSPCs) that are clonally enriched by serially exposing c-kit positive cells to a BET inhibitor.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: February 20, 2018
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Mark A. Dawson, Chun Yew Fong
  • Publication number: 20170260510
    Abstract: Bromodomain and extra terminal protein (BET) resistant leukemic cell lines and methods for producing such cell lines are described as are methods for using such cell lines in screening assays to identify therapeutic agents. The cell lines can be generated from haematopoietic stem and progenitor cells (HSPCs) that are clonally enriched by serially exposing c-kit positive cells to a BET inhibitor.
    Type: Application
    Filed: March 11, 2016
    Publication date: September 14, 2017
    Inventors: Mark A. Dawson, Chun Yew Fong
  • Publication number: 20120151978
    Abstract: A pipe production system includes a plurality of platform segments that are coupled together at a construction site to form a work platform. A helical pipe production system is mounted on the work platform. The work platform includes an integrated drive system that enables the platform to be moved around the terrain of the construction site so that pipe can be produced in-line with an intended or desire pipe laying path.
    Type: Application
    Filed: December 6, 2011
    Publication date: June 21, 2012
    Inventors: William L. Zepp, Daniel W. Aberle, Darrell J. Sanders, Mark A. Dawson